JP2017528496A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528496A5 JP2017528496A5 JP2017515948A JP2017515948A JP2017528496A5 JP 2017528496 A5 JP2017528496 A5 JP 2017528496A5 JP 2017515948 A JP2017515948 A JP 2017515948A JP 2017515948 A JP2017515948 A JP 2017515948A JP 2017528496 A5 JP2017528496 A5 JP 2017528496A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrogen
- fluorine
- group
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *c1c(C(N*=C)=O)c(*)cc(*#C)c1 Chemical compound *c1c(C(N*=C)=O)c(*)cc(*#C)c1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14186082.5 | 2014-09-24 | ||
| EP14186082 | 2014-09-24 | ||
| PCT/EP2015/071656 WO2016046164A1 (de) | 2014-09-24 | 2015-09-22 | Substituierte oxopyridin-derivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017528496A JP2017528496A (ja) | 2017-09-28 |
| JP2017528496A5 true JP2017528496A5 (enExample) | 2018-10-11 |
| JP6517925B2 JP6517925B2 (ja) | 2019-05-22 |
Family
ID=51589181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017515948A Expired - Fee Related JP6517925B2 (ja) | 2014-09-24 | 2015-09-22 | 置換されたオキソピリジン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170298052A1 (enExample) |
| EP (1) | EP3197873B1 (enExample) |
| JP (1) | JP6517925B2 (enExample) |
| CN (1) | CN106687458B (enExample) |
| CA (1) | CA2961981A1 (enExample) |
| ES (1) | ES2713624T3 (enExample) |
| WO (1) | WO2016046164A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3197896B1 (de) * | 2014-09-24 | 2019-01-30 | Bayer Pharma Aktiengesellschaft | Substituierte oxopyridin-derivate |
| JP2018509426A (ja) * | 2015-03-19 | 2018-04-05 | バイエル ファーマ アクチエンゲゼルシャフト | 血栓症の治療のための因子ＸＩａ阻害剤としてのオキソピリジン誘導体 |
| JO3703B1 (ar) | 2015-07-09 | 2021-01-31 | Bayer Pharma AG | مشتقات أوكسوبيريدين مستبدلة |
| UA126251C2 (uk) * | 2018-02-27 | 2022-09-07 | Джянгсу Хенгруй Медісін Ко., Лтд. | Кристалічна форма похідної оксопіколінаміду та спосіб її отримання |
| SG11202008352YA (en) | 2018-04-10 | 2020-09-29 | Bayer Pharma AG | A substituted oxopyridine derivative |
| WO2020127508A1 (en) | 2018-12-21 | 2020-06-25 | Bayer Aktiengesellschaft | Substituted oxopyridine derivatives |
| BR112021009435A2 (pt) | 2018-12-21 | 2021-08-17 | Bayer Aktiengesellschaft | derivados de oxopiridina substituída |
| CN112022848B (zh) * | 2020-08-13 | 2022-02-22 | 中南大学湘雅二医院 | 索拉非尼在治疗1型糖尿病中的应用 |
| CN115947680B (zh) * | 2021-10-09 | 2025-09-23 | 山东新时代药业有限公司 | 一种替罗非班中间体化合物及其制备方法 |
| CN116262740A (zh) * | 2022-11-18 | 2023-06-16 | 成都施贝康生物医药科技有限公司 | 新型氧代吡啶类化合物及其制备方法和用途 |
| CN116535392B (zh) * | 2023-06-26 | 2023-09-05 | 成都施贝康生物医药科技有限公司 | 一种氧代吡啶类化合物的制备方法及中间体和应用 |
| CN116751136B (zh) * | 2023-06-21 | 2025-08-29 | 成都施贝康生物医药科技有限公司 | 氧代吡啶类化合物的新型制备方法及关键中间体 |
| CN116874387B (zh) * | 2023-06-21 | 2025-08-26 | 成都施贝康生物医药科技有限公司 | 氧代吡啶类化合物的新型制备方法及关键中间体 |
| CN116730861A (zh) * | 2023-06-21 | 2023-09-12 | 成都施贝康生物医药科技有限公司 | 氧代吡啶类化合物的新型制备方法及关键中间体 |
| CN117164566B (zh) * | 2023-09-07 | 2025-06-06 | 成都施贝康生物医药科技有限公司 | 一种氧代哒嗪类化合物及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| US7763608B2 (en) * | 2006-05-05 | 2010-07-27 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
| US8163779B2 (en) * | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
| GB2497806A (en) * | 2011-12-21 | 2013-06-26 | Ono Pharmaceutical Co | Pyridinone and pyrimidinone derivatives as factor XIa inhibitors |
| CN104136431B (zh) * | 2011-12-21 | 2017-03-15 | 小野药品工业株式会社 | 作为凝血因子XIa抑制剂的吡啶酮和嘧啶酮衍生物 |
-
2015
- 2015-09-22 WO PCT/EP2015/071656 patent/WO2016046164A1/de not_active Ceased
- 2015-09-22 ES ES15766512T patent/ES2713624T3/es active Active
- 2015-09-22 CA CA2961981A patent/CA2961981A1/en not_active Abandoned
- 2015-09-22 EP EP15766512.6A patent/EP3197873B1/de not_active Not-in-force
- 2015-09-22 JP JP2017515948A patent/JP6517925B2/ja not_active Expired - Fee Related
- 2015-09-22 CN CN201580051690.6A patent/CN106687458B/zh not_active Expired - Fee Related
- 2015-09-22 US US15/513,988 patent/US20170298052A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017528496A5 (enExample) | ||
| JP2016535031A5 (enExample) | ||
| JP2016515562A5 (enExample) | ||
| JP2016525136A5 (enExample) | ||
| JP2016535732A5 (enExample) | ||
| JP2018519323A5 (enExample) | ||
| PH12015502249A1 (en) | Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders | |
| JP7034935B2 (ja) | ピロロ［１，２－ａ］ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用 | |
| CN105636951A (zh) | 酰胺类衍生物及其可药用盐、其制备方法及其在医药上的应用 | |
| RU2009136445A (ru) | Способ получения высокочистого празугрель гидрохлорида | |
| JP2014114295A5 (enExample) | ||
| JP2014509316A5 (enExample) | ||
| JP2012041365A5 (enExample) | ||
| JP2018516883A5 (enExample) | ||
| JP2016539092A5 (enExample) | ||
| JP2012532112A5 (enExample) | ||
| JP2018509426A5 (enExample) | ||
| JP2009510044A5 (enExample) | ||
| RU2016137678A (ru) | Соединения с эфирными группами для лечения опосредованных комплементом нарушений | |
| JP2014508811A5 (enExample) | ||
| CA2864222A1 (en) | Cycloalkane derivative | |
| JP2015514061A5 (enExample) | ||
| JP2016503785A5 (enExample) | ||
| JP2019531279A5 (enExample) | ||
| JP2014503001A5 (enExample) |